id
stringlengths 11
11
| tags
stringlengths 10
513
| text
stringlengths 3
1.35k
| entities
dict | ner_tags
sequencelengths 1
222
| tokens
sequencelengths 1
222
| __index_level_0__
int64 0
7.36k
|
|---|---|---|---|---|---|---|
NCT02930018 | 15:47:chronic_disease | Patient has a severe or fatal comorbid illness that will prevent improvement or follow-up | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "severe or fatal comorbid illness",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] | [
"Patient",
"has",
"a",
"severe",
"or",
"fatal",
"comorbid",
"illness",
"that",
"will",
"prevent",
"improvement",
"or",
"follow-up"
] | 3,797 |
NCT02926924 | 10:25:chronic_disease | Previous spine infection | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "spine infection",
"treatment": null
} | [
0,
0,
2
] | [
"Previous",
"spine",
"infection"
] | 3,802 |
NCT02304458 | 1:38:treatment,34:37:treatment,39:64:treatment,,,130:158:treatment,160:176:treatment, | External beam radiation therapy (XRT)/external beam irradiation including protons: >= 14 days after local XRT; >= 150 days after total body irradiation (TBI), craniospinal XRT or if radiation to >= 50% of the pelvis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "craniospinal XRT"
} | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1
] | [
"External",
"beam",
"radiation",
"therapy",
"(XRT)/external",
"beam",
"irradiation",
"including",
"protons:",
">=",
"14",
"days",
"after",
"local",
"XRT;",
">=",
"150",
"days",
"after",
"total",
"body",
"irradiation",
"(TBI),",
"craniospinal",
"XRT",
"or",
"if",
"radiation",
"to",
">=",
"50%",
"of",
"the",
"pelvis"
] | 6,518 |
NCT02312245 | 14:24:cancer,,71:96:cancer,100:131:cancer | Other active malignancy =< 3 years prior to registration; EXCEPTIONS: non-melanotic skin cancer or carcinoma-in-situ of the cervix | {
"allergy_name": null,
"cancer": "carcinoma-in-situ of the cervix",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
2
] | [
"Other",
"active",
"malignancy",
"=<",
"3",
"years",
"prior",
"to",
"registration;",
"EXCEPTIONS:",
"non-melanotic",
"skin",
"cancer",
"or",
"carcinoma-in-situ",
"of",
"the",
"cervix"
] | 6,505 |
NCT03069469 | 1:23:chronic_disease | Malabsorption syndrome or other illness that could affect oral absorption | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Malabsorption syndrome",
"treatment": null
} | [
0,
2,
0,
0,
2,
0,
0,
0,
0,
0
] | [
"Malabsorption",
"syndrome",
"or",
"other",
"illness",
"that",
"could",
"affect",
"oral",
"absorption"
] | 2,311 |
NCT02272998 | 20:25:cancer,39:45:treatment,152:170:treatment | Patients must have tumor suitable for biopsy (as assessed by trained specialists in interventional radiology) and medically fit to undergo a biopsy or surgical procedure | {
"allergy_name": null,
"cancer": "tumor",
"chronic_disease": null,
"treatment": "surgical procedure"
} | [
0,
0,
0,
3,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] | [
"Patients",
"must",
"have",
"tumor",
"suitable",
"for",
"biopsy",
"(as",
"assessed",
"by",
"trained",
"specialists",
"in",
"interventional",
"radiology)",
"and",
"medically",
"fit",
"to",
"undergo",
"a",
"biopsy",
"or",
"surgical",
"procedure"
] | 6,551 |
NCT02414178 | 34:42:chronic_disease | Cognitively normal, or with mild dementia, as assessed clinically | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "dementia",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Cognitively",
"normal,",
"or",
"with",
"mild",
"dementia,",
"as",
"assessed",
"clinically"
] | 1,346 |
NCT03158519 | 27:37:cancer | Diagnosis of other active malignancy | {
"allergy_name": null,
"cancer": "malignancy",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
2
] | [
"Diagnosis",
"of",
"other",
"active",
"malignancy"
] | 400 |
NCT02525861 | 31:44:treatment,48:69:treatment,79:87:treatment,92:103:treatment,,,266:280:treatment,298:314:treatment | If a participant is receiving anticoagulant or anti-platelet therapy (such as warfarin and clopidogrel), the participant is unwilling to or unable to safely discontinue anticoagulant or anti-platelet therapy within 7 days prior to until at least 24 hours after the BAL procedures. An exception is low-dose aspirin alone which is allowed | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "low-dose aspirin"
} | [
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] | [
"If",
"a",
"participant",
"is",
"receiving",
"anticoagulant",
"or",
"anti-platelet",
"therapy",
"(such",
"as",
"warfarin",
"and",
"clopidogrel),",
"the",
"participant",
"is",
"unwilling",
"to",
"or",
"unable",
"to",
"safely",
"discontinue",
"anticoagulant",
"or",
"anti-platelet",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"until",
"at",
"least",
"24",
"hours",
"after",
"the",
"BAL",
"procedures.",
"An",
"exception",
"is",
"low-dose",
"aspirin",
"alone",
"which",
"is",
"allowed"
] | 6,059 |
NCT02418195 | 1:12:chronic_disease, | Head injury of loss of consciousness in the past 6 months | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Head injury",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Head",
"injury",
"of",
"loss",
"of",
"consciousness",
"in",
"the",
"past",
"6",
"months"
] | 2,585 |
NCT02433626 | 9:14:cancer | Part 2: HNSCC, with confirmed p53 mutations | {
"allergy_name": null,
"cancer": "HNSCC",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"Part",
"2:",
"HNSCC,",
"with",
"confirmed",
"p53",
"mutations"
] | 2,870 |
NCT02105766 | 76:91:treatment | Major anticipated illness or organ failure incompatible with survival from PBSC transplant | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "PBSC transplant"
} | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Major",
"anticipated",
"illness",
"or",
"organ",
"failure",
"incompatible",
"with",
"survival",
"from",
"PBSC",
"transplant"
] | 4,864 |
NCT02575404 | 41:60:treatment | Patients who have previously received a galectin antagonist | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "galectin antagonist"
} | [
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"who",
"have",
"previously",
"received",
"a",
"galectin",
"antagonist"
] | 4,143 |
NCT01505569 | 1:56:cancer | Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET) | {
"allergy_name": null,
"cancer": "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
3,
0
] | [
"Supra-tentorial",
"Primative",
"Neuro-Ectodermal",
"Tumor",
"(PNET)"
] | 5,223 |
NCT02002260 | 12:20:treatment,24:36:treatment,70:74:treatment,78:85:treatment | History of ablation or hysterectomy or have any contraindications to COCs or LNG-IUS | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "LNG-IUS"
} | [
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"History",
"of",
"ablation",
"or",
"hysterectomy",
"or",
"have",
"any",
"contraindications",
"to",
"COCs",
"or",
"LNG-IUS"
] | 6,884 |
NCT01238120 | 20:29:allergy_name | Have an allergy to ibuprofen | {
"allergy_name": "ibuprofen",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
4
] | [
"Have",
"an",
"allergy",
"to",
"ibuprofen"
] | 3,099 |
NCT02181478 | 1:33:cancer | Acute myelogenous leukemia (AML) | {
"allergy_name": null,
"cancer": "Acute myelogenous leukemia (AML)",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
3,
0
] | [
"Acute",
"myelogenous",
"leukemia",
"(AML)"
] | 2,756 |
NCT02128906 | ,,53:65:treatment | Pregnant women are excluded from this study because chemotherapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"chemotherapy"
] | 353 |
NCT02975986 | 76:89:chronic_disease,, | In the Control group (N=10), we will include volunteers with no history of stone disease matched for age (within 5 years) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "stone disease",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"In",
"the",
"Control",
"group",
"(N=10),",
"we",
"will",
"include",
"volunteers",
"with",
"no",
"history",
"of",
"stone",
"disease",
"matched",
"for",
"age",
"(within",
"5",
"years)"
] | 3,751 |
NCT01526603 | 40:52:treatment | Recovery from last induction course of chemotherapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
0,
0,
1
] | [
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] | 740 |
NCT01312857 | ,,31:40:treatment | Lab values ≤ 14 days prior to treatment start: | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"Lab",
"values",
"≤",
"14",
"days",
"prior",
"to",
"treatment",
"start:"
] | 1,229 |
NCT02336451 | 104:128:treatment | Patients must wait for the central laboratory result of the ALK rearrangement status before initiating treatment with ceritinib | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment with ceritinib"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
1,
0,
1
] | [
"Patients",
"must",
"wait",
"for",
"the",
"central",
"laboratory",
"result",
"of",
"the",
"ALK",
"rearrangement",
"status",
"before",
"initiating",
"treatment",
"with",
"ceritinib"
] | 4,580 |
NCT01959698 | 1:19:chronic_disease, | Myocardial infarct within 6 months before enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Myocardial infarct",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"Myocardial",
"infarct",
"within",
"6",
"months",
"before",
"enrollment"
] | 4,999 |
NCT01928589 | 73:85:treatment | Patient must have a Medical Oncology consult with the recommendation of chemotherapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Patient",
"must",
"have",
"a",
"Medical",
"Oncology",
"consult",
"with",
"the",
"recommendation",
"of",
"chemotherapy"
] | 724 |
NCT02950337 | 36:47:cancer | Patients with any prior history of lung cancer | {
"allergy_name": null,
"cancer": "lung cancer",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
3
] | [
"Patients",
"with",
"any",
"prior",
"history",
"of",
"lung",
"cancer"
] | 2,296 |
NCT01459107 | 7:33:chronic_disease,38:55:chronic_disease,95:102:treatment | Mixed connective tissue diseases and collagen diseases can result in poor wound healing after surgery | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "collagen diseases",
"treatment": "surgery"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Mixed",
"connective",
"tissue",
"diseases",
"and",
"collagen",
"diseases",
"can",
"result",
"in",
"poor",
"wound",
"healing",
"after",
"surgery"
] | 7,207 |
NCT02741791 | 51:76:treatment | History of inadequate response to 1 or 2 adequate antidepressant treatments | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "antidepressant treatments"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"History",
"of",
"inadequate",
"response",
"to",
"1",
"or",
"2",
"adequate",
"antidepressant",
"treatments"
] | 3,987 |
NCT02496611 | 36:63:cancer | Personal- and/or family history of medullary thyroid carcinoma | {
"allergy_name": null,
"cancer": "medullary thyroid carcinoma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
2,
3
] | [
"Personal-",
"and/or",
"family",
"history",
"of",
"medullary",
"thyroid",
"carcinoma"
] | 4,308 |
NCT02416206 | 66:70:treatment, | Availability of Cryopreserved peripheral blood stem cells with a CD34 dose of at least 2x106/kg | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "CD34"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] | [
"Availability",
"of",
"Cryopreserved",
"peripheral",
"blood",
"stem",
"cells",
"with",
"a",
"CD34",
"dose",
"of",
"at",
"least",
"2x106/kg"
] | 4,455 |
NCT02140255 | 10:13:chronic_disease | Presumed HIV infection defined as greater than or equal to one positive rapid HIV antibody test obtained in the peripartum period | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0
] | [
"Presumed",
"HIV",
"infection",
"defined",
"as",
"greater",
"than",
"or",
"equal",
"to",
"one",
"positive",
"rapid",
"HIV",
"antibody",
"test",
"obtained",
"in",
"the",
"peripartum",
"period"
] | 168 |
NCT02841956 | 13:22:chronic_disease, | Duration of psychosis > 2 years | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "psychosis",
"treatment": null
} | [
0,
0,
1,
0,
0,
0
] | [
"Duration",
"of",
"psychosis",
">",
"2",
"years"
] | 1,607 |
NCT02495415 | 26:46:chronic_disease | Patients with any active hepatitis infections | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "hepatitis infections",
"treatment": null
} | [
0,
0,
0,
0,
2,
0
] | [
"Patients",
"with",
"any",
"active",
"hepatitis",
"infections"
] | 4,313 |
NCT02660528 | 23:41:chronic_disease,53:71:chronic_disease,76:102:chronic_disease | History of or current autoimmune disease, including multiple sclerosis and inflammatory bowel disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "inflammatory bowel disease",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"History",
"of",
"or",
"current",
"autoimmune",
"disease,",
"including",
"multiple",
"sclerosis",
"and",
"inflammatory",
"bowel",
"disease"
] | 5,848 |
NCT02950337 | 1:23:chronic_disease | Pulmonary hypertension | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Pulmonary hypertension",
"treatment": null
} | [
0,
1
] | [
"Pulmonary",
"hypertension"
] | 2,444 |
NCT02465060 | 1:25:chronic_disease,29:49:treatment,54:62:treatment | Unstable angina pectoris or coronary angioplasty, or stenting | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Unstable angina pectoris",
"treatment": "stenting"
} | [
0,
2,
0,
0,
0,
0,
0,
1
] | [
"Unstable",
"angina",
"pectoris",
"or",
"coronary",
"angioplasty,",
"or",
"stenting"
] | 6,228 |
NCT02213913 | 34:52:chronic_disease,54:77:chronic_disease,79:105:chronic_disease,124:137:chronic_disease | (with exception of patients with Gilbert's syndrome, asymptomatic gallstones, liver involvement with NHL or stable chronic liver disease per investigator assessment) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "liver disease",
"treatment": null
} | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"(with",
"exception",
"of",
"patients",
"with",
"Gilbert's",
"syndrome,",
"asymptomatic",
"gallstones,",
"liver",
"involvement",
"with",
"NHL",
"or",
"stable",
"chronic",
"liver",
"disease",
"per",
"investigator",
"assessment)"
] | 6,617 |
NCT01928576 | ,,53:63:treatment,65:76:treatment,82:91:treatment,126:137:treatment,141:154:treatment | Pregnant women are excluded from this study because entinostat, azacitidine, and Nivolumab are agents with the potential for teratogenic or abortifacient effects | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "abortifacient"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"entinostat,",
"azacitidine,",
"and",
"Nivolumab",
"are",
"agents",
"with",
"the",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects"
] | 6,965 |
NCT02171104 | 1:28:chronic_disease | Globoid cell leukodystrophy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Globoid cell leukodystrophy",
"treatment": null
} | [
0,
0,
0
] | [
"Globoid",
"cell",
"leukodystrophy"
] | 4,768 |
NCT02637349 | 1:15:chronic_disease | Severe illness that would preclude conversation or interface with a computer (e.g.,persistent nausea/vomiting, severe pain) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Severe illness",
"treatment": null
} | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Severe",
"illness",
"that",
"would",
"preclude",
"conversation",
"or",
"interface",
"with",
"a",
"computer",
"(e.g.,persistent",
"nausea/vomiting,",
"severe",
"pain)"
] | 4,054 |
NCT02419495 | ,,,97:106:treatment,, | Negative serum pregnancy test in women of childbearing potential within 7 days of first dose of treatment and patients of child-bearing potential must agree to use effective contraception during/after 3 months post dose | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Negative",
"serum",
"pregnancy",
"test",
"in",
"women",
"of",
"childbearing",
"potential",
"within",
"7",
"days",
"of",
"first",
"dose",
"of",
"treatment",
"and",
"patients",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"effective",
"contraception",
"during/after",
"3",
"months",
"post",
"dose"
] | 1,051 |
NCT02857283 | 23:45:chronic_disease | including significant cardiovascular disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "cardiovascular disease",
"treatment": null
} | [
0,
0,
0,
0
] | [
"including",
"significant",
"cardiovascular",
"disease"
] | 1,539 |
NCT02578732 | 13:23:chronic_disease | Preexisting neuropathy is not allowed from any cause | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "neuropathy",
"treatment": null
} | [
0,
2,
0,
0,
0,
0,
0,
0
] | [
"Preexisting",
"neuropathy",
"is",
"not",
"allowed",
"from",
"any",
"cause"
] | 1,817 |
NCT01811498 | ,,124:133:treatment | Patients must agree to use a medically effective method of contraception during and for a period of three months after the treatment period | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"Patients",
"must",
"agree",
"to",
"use",
"a",
"medically",
"effective",
"method",
"of",
"contraception",
"during",
"and",
"for",
"a",
"period",
"of",
"three",
"months",
"after",
"the",
"treatment",
"period"
] | 1,209 |
NCT02214550 | 8:31:chronic_disease, | active genitourinary infection in the last four weeks | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "genitourinary infection",
"treatment": null
} | [
0,
0,
2,
0,
0,
0,
0,
0
] | [
"active",
"genitourinary",
"infection",
"in",
"the",
"last",
"four",
"weeks"
] | 4,722 |
NCT02921022 | 13:25:treatment,27:34:treatment,36:48:treatment,53:76:treatment | no previous radiotherapy, surgery, chemotherapy, or investigational therapy for the treatment of PDAC | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "investigational therapy"
} | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0
] | [
"no",
"previous",
"radiotherapy,",
"surgery,",
"chemotherapy,",
"or",
"investigational",
"therapy",
"for",
"the",
"treatment",
"of",
"PDAC"
] | 5,725 |
NCT01620216 | 11:43:treatment | No active graft versus host disease (GVHD) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "graft versus host disease (GVHD)"
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"No",
"active",
"graft",
"versus",
"host",
"disease",
"(GVHD)"
] | 5,171 |
NCT02451215 | ,,17:23:cancer | Grade III or IV glioma | {
"allergy_name": null,
"cancer": "glioma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
3
] | [
"Grade",
"III",
"or",
"IV",
"glioma"
] | 4,410 |
NCT01842399 | 8:17:treatment,65:84:treatment,86:106:treatment,108:129:treatment,131:150:treatment,152:170:treatment,174:210:treatment,251:262:treatment,308:321:treatment | Taking medicines that may increase the risk of bleeding such as Coumadin (warfarin), Plavix (clopidogrel), Xarelto (rivaroxaban), Pradaxa (dabgatran), Eliquis (apixaban) or Heparin (blood thinning medications) due to their potential interaction with resveratrol and the increased risk for bleeding with the muscle biopsy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "muscle biopsy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Taking",
"medicines",
"that",
"may",
"increase",
"the",
"risk",
"of",
"bleeding",
"such",
"as",
"Coumadin",
"(warfarin),",
"Plavix",
"(clopidogrel),",
"Xarelto",
"(rivaroxaban),",
"Pradaxa",
"(dabgatran),",
"Eliquis",
"(apixaban)",
"or",
"Heparin",
"(blood",
"thinning",
"medications)",
"due",
"to",
"their",
"potential",
"interaction",
"with",
"resveratrol",
"and",
"the",
"increased",
"risk",
"for",
"bleeding",
"with",
"the",
"muscle",
"biopsy"
] | 7,039 |
NCT01436968 | 1:26:cancer | Localized prostate cancer meeting the NCCN criteria of Intermediate Risk or patients having only one NCCN high-risk feature | {
"allergy_name": null,
"cancer": "Localized prostate cancer",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Localized",
"prostate",
"cancer",
"meeting",
"the",
"NCCN",
"criteria",
"of",
"Intermediate",
"Risk",
"or",
"patients",
"having",
"only",
"one",
"NCCN",
"high-risk",
"feature"
] | 3,470 |
NCT01625234 | 24:46:chronic_disease | Clinically significant cardiovascular disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "cardiovascular disease",
"treatment": null
} | [
0,
0,
0,
0
] | [
"Clinically",
"significant",
"cardiovascular",
"disease"
] | 1,555 |
NCT01597518 | 1:11:treatment | Mexiletine | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "Mexiletine"
} | [
1
] | [
"Mexiletine"
] | 5,180 |
NCT02549937 | 24:48:chronic_disease,67:74:chronic_disease,75:89:chronic_disease,93:111:chronic_disease,116:133:chronic_disease,151:173:cancer,269:302:chronic_disease,306:317:chronic_disease | History or presence of digestive tract diseases, including active gastric/duodenal ulcer or ulcerative colitis, or active hemorrhage of an unresected gastrointestinal tumor, or an evaluation by investigators of having any other condition that could possibly result in gastrointestinal tract hemorrhage or perforation | {
"allergy_name": null,
"cancer": "gastrointestinal tumor",
"chronic_disease": "perforation",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2
] | [
"History",
"or",
"presence",
"of",
"digestive",
"tract",
"diseases,",
"including",
"active",
"gastric/duodenal",
"ulcer",
"or",
"ulcerative",
"colitis,",
"or",
"active",
"hemorrhage",
"of",
"an",
"unresected",
"gastrointestinal",
"tumor,",
"or",
"an",
"evaluation",
"by",
"investigators",
"of",
"having",
"any",
"other",
"condition",
"that",
"could",
"possibly",
"result",
"in",
"gastrointestinal",
"tract",
"hemorrhage",
"or",
"perforation"
] | 6,007 |
NCT01174121 | ,,136:145:treatment | Patients of both genders must be willing to practice birth control from the time of enrollment on this study and for four months after treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Patients",
"of",
"both",
"genders",
"must",
"be",
"willing",
"to",
"practice",
"birth",
"control",
"from",
"the",
"time",
"of",
"enrollment",
"on",
"this",
"study",
"and",
"for",
"four",
"months",
"after",
"treatment"
] | 1,237 |
NCT02995733 | ,,,147:170:treatment | Participant must also have an ACT score of 19 or less, or a history of one or more exacerbations in the past year that required patient report of systemic corticosteroid use | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "systemic corticosteroid"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"Participant",
"must",
"also",
"have",
"an",
"ACT",
"score",
"of",
"19",
"or",
"less,",
"or",
"a",
"history",
"of",
"one",
"or",
"more",
"exacerbations",
"in",
"the",
"past",
"year",
"that",
"required",
"patient",
"report",
"of",
"systemic",
"corticosteroid",
"use"
] | 3,017 |
NCT02578641 | 1:22:treatment | Adjuvant chemotherapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "Adjuvant chemotherapy"
} | [
0,
1
] | [
"Adjuvant",
"chemotherapy"
] | 4,134 |
NCT02923011 | 18:34:chronic_disease,45:58:chronic_disease,60:72:chronic_disease,83:103:chronic_disease | Patients with an active infection or severe hematological, neurological, or other uncontrolled disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "uncontrolled disease",
"treatment": null
} | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"with",
"an",
"active",
"infection",
"or",
"severe",
"hematological,",
"neurological,",
"or",
"other",
"uncontrolled",
"disease"
] | 5,724 |
NCT03127358 | 37:45:allergy_name,47:58:allergy_name,63:72:allergy_name | Known hypersensitivity (allergy) to elbasvir, grazoprevir, or ribavirin | {
"allergy_name": "ribavirin",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
4
] | [
"Known",
"hypersensitivity",
"(allergy)",
"to",
"elbasvir,",
"grazoprevir,",
"or",
"ribavirin"
] | 5,553 |
NCT00492778 | 28:44:treatment,46:52:treatment,57:78:treatment | Patients who have received previous vaginal, pelvic, or abdominal irradiation | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "abdominal irradiation"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"who",
"have",
"received",
"previous",
"vaginal,",
"pelvic,",
"or",
"abdominal",
"irradiation"
] | 7,338 |
NCT02146924 | 39:52:treatment,146:177:treatment,189:229:treatment | If research participant is undergoing leukapheresis and the research participant has undergone prior alloSCT, two months must have elapsed since allogeneic stem cell transplant to undergo PBMC collection for T cell manufacturing | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "PBMC collection for T cell manufacturing"
} | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"If",
"research",
"participant",
"is",
"undergoing",
"leukapheresis",
"and",
"the",
"research",
"participant",
"has",
"undergone",
"prior",
"alloSCT,",
"two",
"months",
"must",
"have",
"elapsed",
"since",
"allogeneic",
"stem",
"cell",
"transplant",
"to",
"undergo",
"PBMC",
"collection",
"for",
"T",
"cell",
"manufacturing"
] | 6,702 |
NCT00625417 | 1:28:treatment | excisional biopsy procedure | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "excisional biopsy procedure"
} | [
0,
1,
0
] | [
"excisional",
"biopsy",
"procedure"
] | 5,349 |
NCT01595061 | 54:90:cancer | Patients with locally advanced, previously untreated squamous cell carcinoma of the vulva | {
"allergy_name": null,
"cancer": "squamous cell carcinoma of the vulva",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0
] | [
"Patients",
"with",
"locally",
"advanced,",
"previously",
"untreated",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"vulva"
] | 5,185 |
NCT02266719 | 12:38:chronic_disease,45:67:chronic_disease,69:86:chronic_disease,134:172:treatment,176:195:treatment,205:219:treatment,226:235:treatment,272:297:treatment | History of connective tissue disorder (e.g. vascular Ehlers Danlos, Marfan's syndrome), with the exception of those patients who had prior open surgical aortic replacement or endovascular repair, where a surgical graft or an endograft would serve as landing zone for the investigational endograft | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Marfan's syndrome",
"treatment": "investigational endograft"
} | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"History",
"of",
"connective",
"tissue",
"disorder",
"(e.g.",
"vascular",
"Ehlers",
"Danlos,",
"Marfan's",
"syndrome),",
"with",
"the",
"exception",
"of",
"those",
"patients",
"who",
"had",
"prior",
"open",
"surgical",
"aortic",
"replacement",
"or",
"endovascular",
"repair,",
"where",
"a",
"surgical",
"graft",
"or",
"an",
"endograft",
"would",
"serve",
"as",
"landing",
"zone",
"for",
"the",
"investigational",
"endograft"
] | 6,565 |
NCT02115295 | 74:86:treatment | Patient with documented hypersensitivity to any of the components of the chemotherapy program | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] | 717 |
NCT01532687 | 12:29:chronic_disease,31:59:chronic_disease,64:87:chronic_disease | History of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "intra-abdominal abscess",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"History",
"of",
"abdominal",
"fistula,",
"gastrointestinal",
"perforation,",
"or",
"intra-abdominal",
"abscess"
] | 5,430 |
NCT02310464 | ,95:104:treatment | Subjects of child-bearing potential must agree to use acceptable contraceptive methods during treatment and until the end of the study | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] | [
"Subjects",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"acceptable",
"contraceptive",
"methods",
"during",
"treatment",
"and",
"until",
"the",
"end",
"of",
"the",
"study"
] | 1,093 |
NCT01893554 | 90:97:treatment | whose parent/guardian understands and signs the study informed consent and who agrees to vaccine administration following a detailed explanation of the study | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "vaccine"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"whose",
"parent/guardian",
"understands",
"and",
"signs",
"the",
"study",
"informed",
"consent",
"and",
"who",
"agrees",
"to",
"vaccine",
"administration",
"following",
"a",
"detailed",
"explanation",
"of",
"the",
"study"
] | 2,012 |
NCT02013154 | 7:35:cancer | Known osteoblastic bony metastasis | {
"allergy_name": null,
"cancer": "osteoblastic bony metastasis",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
1
] | [
"Known",
"osteoblastic",
"bony",
"metastasis"
] | 4,951 |
NCT03139227 | ,,47:59:treatment | Must be > 1 year from pregnancy, lactation or chemotherapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Must",
"be",
">",
"1",
"year",
"from",
"pregnancy,",
"lactation",
"or",
"chemotherapy"
] | 678 |
NCT01829958 | 38:47:treatment | Must meet criteria for initiation of treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
1
] | [
"Must",
"meet",
"criteria",
"for",
"initiation",
"of",
"treatment"
] | 1,201 |
NCT02479620 | 7:15:chronic_disease | Acute thrombus in the target limb | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "thrombus",
"treatment": null
} | [
0,
2,
0,
0,
0,
0
] | [
"Acute",
"thrombus",
"in",
"the",
"target",
"limb"
] | 3,249 |
NCT02178566 | 17:49:treatment, | Initiation of a pulmonary rehabilitation program within 3 months prior to screening or initiation or changes during the study | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "pulmonary rehabilitation program"
} | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Initiation",
"of",
"a",
"pulmonary",
"rehabilitation",
"program",
"within",
"3",
"months",
"prior",
"to",
"screening",
"or",
"initiation",
"or",
"changes",
"during",
"the",
"study"
] | 4,758 |
NCT02020707 | 27:42:cancer,51:74:cancer,76:90:cancer,102:125:cancer | allowable histologies for cervical cancer include squamous cell carcinoma, adenocarcinoma, and mixed/adenosquamous carcinoma | {
"allergy_name": null,
"cancer": "adenosquamous carcinoma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3
] | [
"allowable",
"histologies",
"for",
"cervical",
"cancer",
"include",
"squamous",
"cell",
"carcinoma,",
"adenocarcinoma,",
"and",
"mixed/adenosquamous",
"carcinoma"
] | 6,860 |
NCT02567422 | 33:36:chronic_disease | patients with poorly controlled HIV | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
0,
0,
0,
0,
2
] | [
"patients",
"with",
"poorly",
"controlled",
"HIV"
] | 103 |
NCT02041936 | 1:20:treatment | pancuronium bromide | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "pancuronium bromide"
} | [
0,
0
] | [
"pancuronium",
"bromide"
] | 4,931 |
NCT02538198 | 1:21:cancer | Plasma cell leukemia | {
"allergy_name": null,
"cancer": "Plasma cell leukemia",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
3
] | [
"Plasma",
"cell",
"leukemia"
] | 3,085 |
NCT00540761 | 8:35:chronic_disease | severe peripheral vascular disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "peripheral vascular disease",
"treatment": null
} | [
0,
0,
0,
0
] | [
"severe",
"peripheral",
"vascular",
"disease"
] | 1,813 |
NCT03153319 | 1:24:chronic_disease,32:70:chronic_disease,81:99:chronic_disease,104:118:chronic_disease,123:158:chronic_disease,169:192:chronic_disease | Demyelinating disorders (e.g., central nervous system [CNS] disorders including multiple sclerosis and optic neuritis and peripheral nervous system disorders including Guillain-Barre syndrome) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Guillain-Barre syndrome",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Demyelinating",
"disorders",
"(e.g.,",
"central",
"nervous",
"system",
"[CNS]",
"disorders",
"including",
"multiple",
"sclerosis",
"and",
"optic",
"neuritis",
"and",
"peripheral",
"nervous",
"system",
"disorders",
"including",
"Guillain-Barre",
"syndrome)"
] | 5,528 |
NCT01185132 | 1:31:cancer, | Microscopic multifocal disease is only allowed when the entire span of identified disease measures 3.0 cm or less | {
"allergy_name": null,
"cancer": "Microscopic multifocal disease",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Microscopic",
"multifocal",
"disease",
"is",
"only",
"allowed",
"when",
"the",
"entire",
"span",
"of",
"identified",
"disease",
"measures",
"3.0",
"cm",
"or",
"less"
] | 5,280 |
NCT02687464 | 39:47:cancer | presentation with an appendix mass or phlegmon (on physical examination and/or imaging) | {
"allergy_name": null,
"cancer": "phlegmon",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] | [
"presentation",
"with",
"an",
"appendix",
"mass",
"or",
"phlegmon",
"(on",
"physical",
"examination",
"and/or",
"imaging)"
] | 4,017 |
NCT02349958 | 1:29:cancer,74:105:cancer,106:120:cancer,141:172:treatment | Primary ovarian cancer (POC) with Stage IC or greater stage Recurrent or persistent ovarian cancer (ROC) Ovarian cancer patients who desire Consolidation Chemotherapy (CC) | {
"allergy_name": null,
"cancer": "Ovarian cancer",
"chronic_disease": null,
"treatment": "Consolidation Chemotherapy (CC)"
} | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
3,
0,
0,
0,
0,
1,
0
] | [
"Primary",
"ovarian",
"cancer",
"(POC)",
"with",
"Stage",
"IC",
"or",
"greater",
"stage",
"Recurrent",
"or",
"persistent",
"ovarian",
"cancer",
"(ROC)",
"Ovarian",
"cancer",
"patients",
"who",
"desire",
"Consolidation",
"Chemotherapy",
"(CC)"
] | 6,436 |
NCT02725567 | 57:81:treatment, | Use of any moderate or strong inducers or inhibitors of cytochrome P450 (CYP) 3A within 2 weeks before Day 1 | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "cytochrome P450 (CYP) 3A"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Use",
"of",
"any",
"moderate",
"or",
"strong",
"inducers",
"or",
"inhibitors",
"of",
"cytochrome",
"P450",
"(CYP)",
"3A",
"within",
"2",
"weeks",
"before",
"Day",
"1"
] | 3,996 |
NCT02227199 | 1:25:chronic_disease | congestive heart failure | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "congestive heart failure",
"treatment": null
} | [
0,
0,
0
] | [
"congestive",
"heart",
"failure"
] | 802 |
NCT01766297 | 40:59:treatment | Breasts technically unsatisfactory for radiation treatment upon the discretion of the treating physician | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "radiation treatment"
} | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] | [
"Breasts",
"technically",
"unsatisfactory",
"for",
"radiation",
"treatment",
"upon",
"the",
"discretion",
"of",
"the",
"treating",
"physician"
] | 2,119 |
NCT02044120 | 28:35:treatment,,58:74:treatment,,90:107:treatment,111:124:treatment | Time elapsed from previous therapy must be ≥ 3 weeks for systemic therapy, ≥ 2 weeks for radiation therapy or major surgery | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "major surgery"
} | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1
] | [
"Time",
"elapsed",
"from",
"previous",
"therapy",
"must",
"be",
"≥",
"3",
"weeks",
"for",
"systemic",
"therapy,",
"≥",
"2",
"weeks",
"for",
"radiation",
"therapy",
"or",
"major",
"surgery"
] | 6,843 |
NCT02383979 | 15:34:treatment | scheduled for elective amputation | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "elective amputation"
} | [
0,
0,
0,
2
] | [
"scheduled",
"for",
"elective",
"amputation"
] | 4,505 |
NCT02955251 | 51:62:cancer,80:89:treatment,93:109:treatment | combination therapy cohorts must have an advanced solid tumor where the use of nivolumab is standard therapy | {
"allergy_name": null,
"cancer": "solid tumor",
"chronic_disease": null,
"treatment": "standard therapy"
} | [
0,
1,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
1,
0,
0,
1
] | [
"combination",
"therapy",
"cohorts",
"must",
"have",
"an",
"advanced",
"solid",
"tumor",
"where",
"the",
"use",
"of",
"nivolumab",
"is",
"standard",
"therapy"
] | 5,702 |
NCT02789228 | 15:25:chronic_disease | Patients with active HIV | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "active HIV",
"treatment": null
} | [
0,
0,
0,
2
] | [
"Patients",
"with",
"active",
"HIV"
] | 3,941 |
NCT02924194 | 8:32:treatment | Use of cholinesterase inhibitor | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "cholinesterase inhibitor"
} | [
0,
0,
0,
0
] | [
"Use",
"of",
"cholinesterase",
"inhibitor"
] | 3,810 |
NCT02774421 | 1:13:cancer | mixed glioma | {
"allergy_name": null,
"cancer": "mixed glioma",
"chronic_disease": null,
"treatment": null
} | [
0,
3
] | [
"mixed",
"glioma"
] | 3,951 |
NCT02621944 | 45:55:chronic_disease | clinical signs and symptoms consistent with meningitis detected upon sepsis evaluation | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "meningitis",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0
] | [
"clinical",
"signs",
"and",
"symptoms",
"consistent",
"with",
"meningitis",
"detected",
"upon",
"sepsis",
"evaluation"
] | 3,190 |
NCT02099058 | 24:55:chronic_disease,51:54:chronic_disease,59:70:chronic_disease,85:117:treatment | Subject has history of interstitial lung disease (ILD) or pneumonitis that required treatment with systemic steroids, or any evidence of active ILD or pneumonitis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "pneumonitis",
"treatment": "treatment with systemic steroids"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] | [
"Subject",
"has",
"history",
"of",
"interstitial",
"lung",
"disease",
"(ILD)",
"or",
"pneumonitis",
"that",
"required",
"treatment",
"with",
"systemic",
"steroids,",
"or",
"any",
"evidence",
"of",
"active",
"ILD",
"or",
"pneumonitis"
] | 6,770 |
NCT02923921 | 27:55:chronic_disease | History of positivity for human immunodeficiency virus | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "human immunodeficiency virus",
"treatment": null
} | [
0,
0,
0,
0,
0,
2,
0
] | [
"History",
"of",
"positivity",
"for",
"human",
"immunodeficiency",
"virus"
] | 2,603 |
NCT02419560 | 11:19:cancer | Known CNS lymphoma | {
"allergy_name": null,
"cancer": "lymphoma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
3
] | [
"Known",
"CNS",
"lymphoma"
] | 1,651 |
NCT01824836 | 20:31:treatment, | Plan to treat with anastrozole for at least 12 months | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "anastrozole"
} | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] | [
"Plan",
"to",
"treat",
"with",
"anastrozole",
"for",
"at",
"least",
"12",
"months"
] | 3,451 |
NCT02350764 | 1:8:treatment,10:16:treatment,18:33:treatment,35:45:treatment,51:74:treatment,59:74:treatment,110:128:chronic_disease | Inhaled, ocular, intra-articular, intranasal, and topical corticosteroids are permitted in absence of active autoimmune disease | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "autoimmune disease",
"treatment": "corticosteroids"
} | [
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Inhaled,",
"ocular,",
"intra-articular,",
"intranasal,",
"and",
"topical",
"corticosteroids",
"are",
"permitted",
"in",
"absence",
"of",
"active",
"autoimmune",
"disease"
] | 6,434 |
NCT03109210 | 1:23:chronic_disease,, | restless legs syndrome (score of >11 in the IRLS) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "restless legs syndrome",
"treatment": null
} | [
0,
0,
2,
0,
0,
0,
0,
0,
0
] | [
"restless",
"legs",
"syndrome",
"(score",
"of",
">11",
"in",
"the",
"IRLS)"
] | 3,009 |
NCT02389023 | ,58:67:treatment | Any groin incision on index leg within 12 weeks prior to treatment initiation | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"Any",
"groin",
"incision",
"on",
"index",
"leg",
"within",
"12",
"weeks",
"prior",
"to",
"treatment",
"initiation"
] | 1,062 |
NCT02078102 | ,45:67:treatment,79:89:treatment,91:105:treatment,107:125:treatment,131:145:treatment,151:173:treatment,185:197:treatment,201:213:treatment,250:259:treatment | Patients must be at least 4 weeks from last cytotoxic chemotherapy (including alkylating, anthracyclines, epipodophylatoxins, and platinum drugs), or immunomodulatory drugs (including lenalidomide or pomalidomide, or related derivatives) at time of treatment on this protocol | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] | [
"Patients",
"must",
"be",
"at",
"least",
"4",
"weeks",
"from",
"last",
"cytotoxic",
"chemotherapy",
"(including",
"alkylating,",
"anthracyclines,",
"epipodophylatoxins,",
"and",
"platinum",
"drugs),",
"or",
"immunomodulatory",
"drugs",
"(including",
"lenalidomide",
"or",
"pomalidomide,",
"or",
"related",
"derivatives)",
"at",
"time",
"of",
"treatment",
"on",
"this",
"protocol"
] | 6,794 |
NCT02832115 | 8:23:chronic_disease | Severe Aortic Stenosis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Aortic Stenosis",
"treatment": null
} | [
0,
0,
0
] | [
"Severe",
"Aortic",
"Stenosis"
] | 3,905 |
NCT02553642 | ,68:79:treatment,83:99:treatment,104:118:cancer | Subjects with disease recurrence within 1 year of a platinum based neoadjuvant or adjuvant therapy for bladder cancer | {
"allergy_name": null,
"cancer": "bladder cancer",
"chronic_disease": null,
"treatment": "adjuvant therapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
3,
3
] | [
"Subjects",
"with",
"disease",
"recurrence",
"within",
"1",
"year",
"of",
"a",
"platinum",
"based",
"neoadjuvant",
"or",
"adjuvant",
"therapy",
"for",
"bladder",
"cancer"
] | 6,002 |
End of preview. Expand
in Dataset Viewer.
- Downloads last month
- 34